2017-07-05 17:27:07 UTC

Crohn's & Colitis Congress Registration Open

July 5, 2017

The Crohn’s & Colitis Congress will take place Jan. 18-20, 2018, in Las Vegas.

Join the Crohn’s & Colitis Foundation and AGA for the inaugural Crohn’s & Colitis Congress™. Expand your knowledge, network with inflammatory bowel diseases (IBD) leaders across multiple disciplines and get inspired to improve patient care.

The Crohn’s & Colitis Congress, taking place Jan. 18-20, 2018 in Las Vegas, combines the strengths of the nation’s leading IBD patient organization, Crohn’s & Colitis Foundation, and the premier GI professional association, AGA. Together we are committed to convening the greatest minds in IBD to transform patient care and accelerate the pace of research.

The Crohn’s & Colitis Congress offers a bold multidisciplinary, clinically-focused and forward-thinking program. The organizing committee and faculty represent key disciplines involved in the comprehensive care of IBD patients, as well as the foremost minds in research.

Sessions will emphasize case studies with multidisciplinary panel discussions covering: 

  • Management of Complicated IBD
  • Defining Optimal Treatment Algorithms
  • Clinical and Research Challenges

Take a critical step towards finding cures and improving the lives of adults and children living with IBD. Learn more about the congress and register today by visiting www.crohnscolitiscongress.org.

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Oct. 22, 2017

We investigated whether serum trough levels of vedolizumab, during the induction phase can determine whether patients need additional doses within 6 months.

Healing of Tonsillar Crohn’s Disease With Infliximab

Oct. 22, 2017